A randomized cross-over trial of granisetron and dexamethasone versus granisetron alone: The role of dexamethasone on day 1 in the control of cisplatin-induced delayed emesis

Japanese Journal of Clinical Oncology

Volumn 26, Issue 3, 1996, Pages 164-168

  Sekine, Ikuo ^a   Nishiwaki, Yutaka ^a   Kakinuma, Ryutaro ^a   Kubota, Kaoru ^a   Hojo, Fumihiko ^a   Matsumoto, Taketoshi ^a   Ohmatsu, Hironobu ^a   Yokozaki, Michiya ^a   Kodama, Tetsuro ^a  

^a NATIONAL CANCER CENTER HOSPITAL EAST   (Japan)

Author keywords

Antiemetics; Chemotherapy; Delayed emesis; Dexamethasone; Granisetron

Indexed keywords

ANTIEMETIC AGENT; ANTINEOPLASTIC AGENT; CISPLATIN; DEXAMETHASONE; GRANISETRON; METOCLOPRAMIDE;

ADULT; AGED; ARTICLE; CHEMICALLY INDUCED DISORDER; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DRUG ADMINISTRATION; DRUG COMBINATION; FEMALE; HUMAN; LUNG TUMOR; MALE; MIDDLE AGED; RANDOMIZED CONTROLLED TRIAL; SINGLE BLIND PROCEDURE; VOMITING;

ADULT; AGED; ANTIEMETICS; ANTINEOPLASTIC AGENTS; CISPLATIN; CROSS-OVER STUDIES; DEXAMETHASONE; DRUG ADMINISTRATION SCHEDULE; DRUG THERAPY, COMBINATION; FEMALE; GRANISETRON; HUMANS; LUNG NEOPLASMS; MALE; METOCLOPRAMIDE; MIDDLE AGED; SINGLE-BLIND METHOD; VOMITING;

EID: 0030161441     PISSN: 03682811     EISSN: None     Source Type: Journal    
DOI: 10.1093/oxfordjournals.jjco.a023201     Document Type: Article

References (12)

1. Del Favero A, Roila F, Tonato M: Reducing chemotherapy-induced nausea and vomiting: current perspectives and future possibilities. Drug Safety 9: 410-428, 1993
2. Gralla RJ: Antiemetic therapy. In Cancer: Principles & Practice of Oncology, 4th ed, DeVita VT, Hellman S, Rosenberg SA, eds, JB Lippincott Co, Philadelphia. p2338-2348, 1993
3. Kris MG, Gralla RJ, Clark RA, Tyson LB, O'Connell JP, Wertheim MS, Kelsen DP: Incidence, course, and severity of delayed nausea and vomiting following the administration of high-dose cisplatin. J Clin Oncol 3: 1379-1384, 1985
4. Shinkai T, Saijo N, Eguchi K, Sasaki Y, Tamura T, Fujiwara Y, Mae M, Fukuda M, Ohe Y, Sasaki S, Nakagawa K, Minato K, Hong WS, Suemasu K: Control of cisplatin-induced delayed emesis with metoclopramide and dexamethasone: a randomized controlled trial. Jpn J Clin Oncol 19: 40-44, 1989
5. Kris MG, Gralla RJ, Tyson LB, Clark RA, Cirrincione C, Groshen S: Controlling delayed vomiting: double-blind, randomized trial comparing placebo, dexamethasone alone, and metoclopramide plus dexamethasone in patients receiving cisplatin. J Clin Oncol 7: 108-114, 1989
6. Moreno I, Resell R, Abad A, Barnadas A, Carles J, Ribelles N, Solano V, Font A: Comparison of three protracted amiemeric regimens for the control of delayed emesis in cisplatin-treated patients. Eur J Cancer 28A: 1344-1347, 1992
7. Italian Group for Antiemetic Research: Ondansetron + dexamethasone vs metoclopramide + dexamethasone + diphenhydramine in prevention of cisplatin-induced emesis. Lancet 340: 96-99, 1992
8. Hills M, Armitage P: The two-period cross-over clinical trial. Br J Clin Pharmac 8: 7-20, 1979
9. Senn S: Cross-over Trials in Clinical Research. John Wiley & Sons Ltd, Chichester. 1993
10. Sorbe B, Högberg T, Himmelmann A, Schmidt M, Räisänen I, Stockmeyer M, de Bruijn KM: Efficacy and tolerability of tropisetron in comparison with a combination of tropisetron and dexamethasone in the control of nausea and vomiting induced by cisplatin-containing chemotherapy. Eur J Cancer 30A: 629-634, 1994
11. Ohmatsu H, Eguchi K, Shinkai T, Tamura T, Ohe Y, Nisio M, Kunikane H, Arioka H, Karato A, Nakashima H, Sasaki Y, Tajima K, Tada N, Saijo N: A randomized cross-over study of high-dose metoclopramide plus dexamethasone versus granisetron plus dexamethasone in patients receiving chemotherapy with high-dose cisplatin. Jpn J Cancer Res 85: 1151-1158, 1994
12. Bakowski MT: Advances in anti-emetic therapy. Cancer Treat Rev 11: 237-256, 1984